Back to results
US 2016/0101169 A1Published application
Breast Cancer Vaccine
AssigneeThe Cleveland Clinic Foundation
InventorsVincent K. Tuohy, Justin M. Johnson, Ritika Jaini
Life of this patent
Estimating the term…
Abstract
Compositions and methods for immunization against human breast cancer are disclosed. A breast cancer vaccine comprises an immunogenic polypeptide comprising human α-lactalbumin.
Claims19
A method of immunizing a non-lactating female human patient against a human α-lactalbumin, the method comprising the steps of
- inducing an immune response against α-lactalbumin in the patient by administering to the patient an immunogenic composition, the immunogenic composition comprising
- an adjuvant;
- and
- a polypeptide comprising a human α-lactalbumin sequence as set forth in SEQ ID NO:
- 1.
2 more elements
An immunogenic composition comprising a polypeptide comprising a human α-lactalbumin sequence as set forth in SEQ ID NO:
- 1, an adjuvant and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.